Prescriber's Corner

Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia

Sarah S. Evans, PharmD, and Amber B. Clemmons, PharmD, BCOP

Georgia Regents Medical Center, Augusta, Georgia, and University of Georgia College of Pharmacy, Augusta, Georgia

Authors' disclosures of potential conflicts of interest are found at the end of this article.

Sarah S. Evans, PharmD, University of Georgia College of Pharmacy, HM-1200, Augusta, GA 30912. E-mail: sevans@gru.edu


J Adv Pract Oncol 2015;6:370–374 | DOI: 10.6004/jadpro.2015.6.4.7 | © 2015 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.